New Brunswick Sees Canada's 3rd Astra Zeneca Blood Clot Case

 It's interesting to notice that this "rare" case of blood clotting is becoming less rare as time goes on. When the news first broke it was widely claimed to be occurring at the rate of one in a million. Now we're looking at 1 every 100,000 to 250,000 injections. One in a million has become 4-10 times in a million. Which of course makes an average of 7 cases in a million injections. 7 times more then one in a million.

CTV

HALIFAX -- New Brunswick reported its first case of blood-clotting in a person who received the Oxford-AstraZeneca COVID-19 vaccine.

Dr. Jennifer Russell, the province's chief medical officer of health, said the person is in their 30s and received the vaccine in mid-March, before the National Advisory Committee on Immunization (NACI) recommendation on March 29 to not give it to anyone younger than 55.

“While every adverse reaction is unfortunate, it is important to remember that these blood clots are extremely rare,” Russell said. “The vaccine helps prevent the much higher risks associated with COVID-19 infections.”

Oh yes, the much higher risks - always inferred never really quantified

•  Blood Clots as Prevalent with Pfizer & Moderna as with AstraZeneca: Blood Clots and Covid link? Questionable.

Russell said that the global frequency of VITT is low and has been estimated at about one case in 100,000 to 250,000 doses of vaccine.

• Perspective on Pandemic: "Blood Clots and Beyond"

• Canada’s Covid Vaccine Weekly Harm and Injury Report: 31 Reported Deaths & 2 Brain Clot Cases